Navigation Links
Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer
Date:11/11/2013

MASON, Ohio, Nov. 11, 2013 /PRNewswire/ -- Aprecia Pharmaceuticals Company ("Aprecia" or "the company") announced today that it has selected Don Wetherhold to serve as the company's next chief executive officer.  Wetherhold previously served as senior vice president, long-term care at Omnicare, Inc.  Prior to his time at Omnicare, Wetherhold was Aprecia's corporate commercialization officer.

"We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role," said E. Thomas Arington, Aprecia's chairman.  "Don was instrumental in devising our commercialization strategy at Aprecia.  We are now preparing to file our first product, and we have two additional products in development.  The company is poised for commercial success, and Don's expertise and commitment certainly augment Aprecia's momentum.

"We also know that Don's extensive experience within the healthcare field will serve both him and the company well.  Furthermore, we highly value not only his experience and intelligence but also his character," Arington concluded.

"I'm excited to be back at Aprecia for a number of reasons, not the least of which is the rare opportunity to be the first at something and redefine a market—which is what our breakthrough 3DP product development and manufacturing system has the potential to do," stated Wetherhold.  "Aprecia's technology is being used to enhance the delivery of gold-standard pharmaceutical products, thereby improving treatment adherence for certain patient populations.  The company's vision is to make medicines easier to take, and Aprecia has made great strides toward that vision this past year." 

Wetherhold has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals.  Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories' senior vice president and general manager of Hampton Laine, Prasco's branded pharmaceutical business.

About Aprecia Pharmaceuticals Company – Aprecia is a unique specialty pharmaceutical company built upon an innovative 3DP (three-dimensional printing) technology and manufacturing system.  Aprecia is the first and only company in the world to utilize this technology to develop and manufacture pharmaceutical products at commercial scale. 

CONTACT: Jeff Zurcher
P 513.204.1200


'/>"/>
SOURCE Aprecia Pharmaceuticals Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ALCOR Scientific Inc. Welcomes New COO
2. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
3. Cosmetic Dermatology of Orange County Welcomes Worlds Most Advanced Technology for Tattoo Removal
4. Connecticuts CURE network welcomes HLK, its first Chinese member company
5. PurThread Technologies Welcomes Life Sciences Veterans to CEO and Board Positions
6. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
7. SkelRegen Welcomes Director of Scientific Affairs to Management Team
8. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
9. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
10. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
11. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research and ... Thalassaemia Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights - 2016, provides comprehensive ... Thalassaemia market valuations and forecast, Thalassaemia products ...
(Date:5/4/2016)... May 4, 2016 According to ... entitled "Brain Computer Interface Market - Global Industry Analysis, Size, ... brain computer interface (BCI) market  is expected to reach ... is estimated to expand at a CAGR of 14.9 ... A BCI device provides collaboration between the ...
(Date:5/4/2016)... -- According to market research "Global Computed Tomography ... 2022 - Industry Insights by Slice Type (High, Mid and ... P&S Market Research, the global computed tomography market ... expected to grow at a CAGR of 5.0% during 2016-2022. ... expected to witness the faster growth, CAGR of 5.3%, during ...
Breaking Medicine Technology:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... conditions and Make-A-Wish grants the most heartfelt wishes of these children. The ... of medical treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson said, ...
(Date:5/5/2016)... ... ... Long Island’s fastest growing comprehensive eye care provider, North Shore Eye ... Valkenburg, MD as part of their ongoing effort to increase ophthalmic coverage in their ... of North Shore Eye Care. , “We are extremely proud to welcome ...
(Date:5/5/2016)... ... ... TIME for Kids and The ZAC Foundation – a national leader in drowning ... million children with important water safety messages before summer break begins. , ... in children one to 6 years of age. TIME for Kids and The ...
(Date:5/5/2016)... ... , ... In honor of National Nurses Week 2016, Aya Healthcare , ... to thank a nurse who's made a difference in their life. From Friday, May ... Cross of San Diego/Imperial Counties (up to $10,000) every time someone tells them via ...
(Date:5/5/2016)... ... ... Lung Institute will celebrate its three-year anniversary on May 14 by giving away a ... of May. To date, the Lung Institute has treated over 2,000 people at their five ... to the success of this treatment and to the patients who refuse to give up,” ...
Breaking Medicine News(10 mins):